Andrew E Place Selected Research

Andrew E Place Research Topics

8	Neoplasms (Cancer) 11/2021 - 07/2003
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2021 - 02/2017
5	Leukemia 01/2022 - 07/2003
3	Residual Neoplasm 11/2021 - 01/2018
2	Osteonecrosis (Kienbock's Disease) 11/2022 - 01/2022
2	Hypersensitivity (Allergy) 11/2021 - 12/2015
2	Pancreatitis 11/2021 - 12/2015
2	Hemorrhage 01/2021 - 12/2015
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2021 - 02/2017
2	Breast Neoplasms (Breast Cancer) 11/2016 - 07/2003
1	Cataract (Cataracts) 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022
1	Lymphoma (Lymphomas) 01/2022
1	Hyperbilirubinemia 11/2021
1	Thrombosis (Thrombus) 11/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Febrile Neutropenia 09/2020
1	Septic Shock (Toxic Shock Syndrome) 09/2020
1	Typhlitis 09/2020
1	Down Syndrome (Down's Syndrome) 09/2020
1	Hematologic Neoplasms (Hematological Malignancy) 09/2018
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 09/2018
1	Pulmonary Arterial Hypertension 01/2018
1	Blast Crisis (Blast Phase) 01/2018
1	Pericardial Effusion 01/2018
1	Pulmonary Edema 01/2018
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2018
1	Carcinoma (Carcinomatosis) 11/2016
1	Mycoses (Diseases, Fungus) 12/2015
1	Disease Progression 01/2011
1	Melanoma (Melanoma, Malignant) 07/2003

6	Pharmaceutical PreparationsIBA 01/2021 - 05/2013
4	Asparaginase (Elspar)FDA Link 11/2022 - 12/2015
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2022 - 02/2017
2	GlucocorticoidsIBA 01/2022 - 02/2017
2	pegaspargase (Oncaspar)FDA Link 11/2021 - 12/2015
2	Everolimus FDA Link 01/2018 - 02/2017
2	Biomarkers (Surrogate Marker)IBA 11/2016 - 01/2011
1	Decitabine FDA Link 01/2022
1	Vorinostat FDA Link 01/2022
1	calaspargase pegolIBA 11/2021
1	Investigational DrugsIBA 04/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Small Cytoplasmic RNAIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Vancomycin FDA LinkGeneric 09/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2020
1	venetoclaxIBA 09/2018
1	Antigen Receptors (Antigen Receptor)IBA 01/2018
1	Imatinib Mesylate (Gleevec)FDA Link 01/2018
1	Dasatinib (BMS 354825)FDA Link 01/2018
1	Azacitidine (5 Azacytidine)FDA Link 01/2018
1	PowdersIBA 01/2018
1	SuspensionsIBA 01/2018
1	TabletsIBA 01/2018
1	ribociclibIBA 02/2017
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 02/2017
1	Methotrexate (Mexate)FDA LinkGeneric 02/2017
1	Drug CombinationsIBA 02/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 02/2017
1	MTOR InhibitorsIBA 02/2017
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 02/2017
1	Cyclin D3IBA 02/2017
1	Hyaluronic Acid (Hyaluronan)IBA 11/2016
1	Lapatinib (GW572016)FDA Link 11/2016
1	1- (2- cyano- 3,12- dioxooleana- 1,9- dien- 28- oyl) imidazoleIBA 07/2003
1	bardoxoloneIBA 07/2003
1	TriterpenesIBA 07/2003

10	Therapeutics 01/2022 - 01/2011
5	Drug Therapy (Chemotherapy) 01/2022 - 01/2018
1	Investigational Therapies (Experimental Therapy) 04/2021